The White House advisory group suggested that pricing frameworks are needed for deciding the value of cancer medicines, a step that is already taken in many other countries.

The White House advisory group suggested that pricing frameworks are needed for deciding the value of cancer medicines, a step that is already taken in many other countries.

Panel Calls For Action On Cancer Drugs: Patients Shouldn’t Have To Choose Between Medication And Mortgage